|
DSCC1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.34400000018076E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.243400E-03 |
| Normal-vs-Stage2 |
2.456100E-02 |
| Normal-vs-Stage3 |
1.999330E-04 |
| Normal-vs-Stage4 |
4.443600E-03 |
| Stage1-vs-Stage2 |
5.680400E-01 |
| Stage1-vs-Stage3 |
1.076600E-03 |
| Stage1-vs-Stage4 |
2.582000E-01 |
| Stage2-vs-Stage3 |
5.611600E-02 |
| Stage2-vs-Stage4 |
4.467600E-01 |
| Stage3-vs-Stage4 |
2.290400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.59110000003326E-06 |
| Normal-vs-AfricanAmerican |
5.018000E-04 |
| Normal-vs-Asian |
9.240300E-02 |
| Caucasian-vs-AfricanAmerican |
5.784200E-01 |
| Caucasian-vs-Asian |
2.780600E-01 |
| AfricanAmerican-vs-Asian |
7.810300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.0426999999974E-05 |
| Normal-vs-Female |
1.9491899999946E-05 |
| Male-vs-Female |
6.577000E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.779400E-04 |
| Normal-vs-Extreme_Weight |
1.939660E-03 |
| Normal-vs-Obese |
2.384800E-04 |
| Normal-vs-Extreme_Obese |
8.351000E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.528400E-01 |
| Normal_Weight-vs-Obese |
3.196800E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.500000E-02 |
| Extreme_Weight-vs-Obese |
5.239700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
1.737030E-01 |
| Obese-vs-Extreme_Obese |
5.622300E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.744700E-03 |
| Normal-vs-Age(41-60Yrs) |
8.21200000000744E-07 |
| Normal-vs-Age(61-80Yrs) |
1.140840E-03 |
| Normal-vs-Age(81-100Yrs) |
2.405700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.482300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.682500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.065800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.202000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.411400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.100200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.196700E-04 |
| Normal-VS-Type2 PRCC |
1.232180E-04 |
| Normal-VS-KIRP CIMP |
5.164600E-03 |
| Normal-VS-Unclassified PRCC |
1.317610E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.335010E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.110380E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.583840E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.755500E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
8.566800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.982230E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.564000E-04 |
| Normal-vs-N1 |
5.993200E-04 |
| Normal-vs-N2 |
2.776200E-01 |
| N0-vs-N1 |
9.904900E-03 |
| N0-vs-N2 |
5.251600E-01 |
| N1-vs-N2 |
5.653200E-01 |
|
|
